Morepen Laboratories shines on the buzz of entering into partnership with Vesale Pharma

09 Nov 2017 Evaluate

Morepen Laboratories is currently trading at Rs. 18.25, up by 0.45 points or 2.53% from its previous closing of Rs. 17.80 on the BSE.

The scrip opened at Rs. 18.60 and has touched a high and low of Rs. 18.70 and Rs. 18.20 respectively. So far 109698 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 25.10 on 09-Nov-2016 and a 52 week low of Rs. 14.80 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 18.95 and Rs. 16.85 respectively. The current market cap of the company is Rs. 820.93 crore.

The promoters holding in the company stood at 34.54%, while institutions and non-institutions held 18.80% and 46.66% respectively.

In a bid to aggressively tap the growing probiotics market in India, Morepen Laboratories has reportedly entered into partnership with Belgium's Vesale Pharma. The move is expected to contribute Rs 100 crore to the Indian company's topline in five years. Moreover, the company will soon be launching four major probiotics developed by Vesale Pharma in the Indian market.

Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.

Morepen Laboratories Share Price

42.42 -1.03 (-2.37%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×